| References |
1. Chen D, Peng C, Xie X, Chen Q, Liu H, Zhang S, Wan F, Ao H. Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats. CNS Neurol Disord Drug Targets. 2017;16(10):1111-1119. doi: 10.2174/1871527316666171026114043. PubMed PMID: 29076436. 2. Wang Q, Gao S, Luo Y, Kang QY. Compound anisodine affects the proliferation and calcium overload of hypoxia-induced rat retinal progenitor cells and brain neural stem cells via the p-ERK1/2/HIF-1α/VEGF pathway. Exp Ther Med. 2017 Jul;14(1):600-608. doi: 10.3892/etm.2017.4528. Epub 2017 May 31. PubMed PMID: 28672973; PubMed Central PMCID: PMC5488403. 3. Liu WD, Chen LL, Shen CY, Jiang LB. Neuroprotective Effect of Compound Anisodine in a Mouse Model with Chronic Ocular Hypertension. Chin Med J (Engl). 2015 Oct 5;128(19):2652-7. doi: 10.4103/0366-6999.166043. PubMed PMID: 26415805; PubMed Central PMCID: PMC4736849. 4. Tian F, Li C, Wang X, Ren S, Li N, Liu Q, Zhou S, Lu Y, Zhao D, Chen X. Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats. Eur J Drug Metab Pharmacokinet. 2015 Sep;40(3):245-53. doi: 10.1007/s13318-014-0192-y. Epub 2014 Apr 20. PubMed PMID: 24748278. |
